Saint Luke's Health System
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Saint Luke's Health System sits in the top decile of US sponsors by registered trial count (#604 of 15,742 sponsors by registered trial count).
Saint Luke's Health System: 26 sponsored US clinical trials, 2 recruiting.
Saint Luke's Health System sponsors 26 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 18 completed. 5 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Chronic Heart Failure With Preserved Systolic Function, with 1 trials.
Top-decile sponsor footprint
Saint Luke's Health System ranks in the top decile of sponsors by registered trial count (#604 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
18 of 23 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (78.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
26 total, page 1 of 1
Quantification of Debris Captured Using TCEP During VIV TAVR With BVF
NCT05093764
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
NCT05388097
The Heart Outcomes in Pregnancy Expectations (H.O.P.E) Registry
NCT04828070
STAR and Deferred Stenting Study
NCT05089864
Implementation of CareCube Negative Pressure Isolation Units
NCT05229926
Dapagliflozin in Respiratory Failure in Patients With COVID-19
NCT04350593
SCOPE CLI (Shifting Care and Outcomes for Patients With Endangered Limbs - Critical Limb Ischemia)
NCT03171259
NICOM in Pregnant Women With Heart Disease
NCT03616730
Release of Acetylcholine From the Ganglionated Plexus During the Thaw Phase of Cryoballon Pulmonary Vein Ablation (GP RESPONSE Study)
NCT03636100
Initial Management of Patients Receiving a Single Shock (IMPRESS)
NCT03531502
VAscular Closure for Cardiac Ablation Registry (VACCAR)
NCT03546439
Better Outcomes for Anticoagulation Treatment Through Observation of Atrial Rhythm
NCT03515083
Empagliflozin Impact on Hemodynamics in Patients With Heart Failure
NCT03030222
SHOWME-PAD (Peripheral Artery Disease)
NCT03190382
Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
NCT03030235
Outcomes of Surgically Ineligible Patients With Multivessel CAD
NCT02996877
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
NCT02653482
One More Magnetic Resonance Imaging
NCT02293070
Outcomes, Patient Health Status, and Efficiency in Chronic Total Occlusion
NCT02026466
Patient-centered Outcomes Related to TReatment Practices in Peripheral Arterial Disease: Investigating Trajectories (PORTRAIT)
NCT01419080
Angina Prevalence and Provider Evaluation of Angina Relief
NCT01705054
Comparison of Different Locations for Pulse Oximetry Probes in Cardiovascular (CV) Patients With Poor Peripheral Perfusion
NCT01128036
Single-Incision Laparoscopic Cholecystectomy Versus Traditional Laparoscopic Cholecystectomy
NCT01195285
Transforming PCI Informed Consent Into an Evidence-based Decision-making Tool
NCT01383382
Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patients
NCT00736229
Diabetes Genome Project: A Prospective Registry to Identify Genetic Variation Among Diabetic Patients
NCT00428961
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
| Phase 4 | 4 |
Where Saint Luke's Health System enrollment is open (later-stage tilt)
2 recruiting of 26 indexed (8% open); 18 completed (69%).
Phase mix: 5 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Chronic Heart Failure With Preserved Systolic Function (1 trial), 6 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Saint Luke's Health System: open-pipeline peers nationwide
Peers matched on 26 registered trials and 8% open enrollment, not the therapeutic-area sidebar.
Saint Luke's Health System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 26 trials (± recruiting share)
- Abbott Diabetes Care · 26 trials · 12% recruiting
- Aldeyra Therapeutics · 26 trials · 4% recruiting
- California Polytechnic State University-San Luis Obispo · 26 trials · 19% recruiting
- DexCom · 26 trials · 4% recruiting
Sponsors near 8% open enrollment (± trial volume)
- Alumis · 8% recruiting · 13 trials
- Andrei Iagaru · 8% recruiting · 13 trials
- BioXcel Therapeutics · 8% recruiting · 13 trials
- Corporal Michael J. Crescenz VA Medical Center · 8% recruiting · 13 trials
Related
What to do with this Saint Luke's Health System page
26 registered trials is a research-attention snapshot, not an endorsement of Saint Luke's Health System or any single study.
- 2 of Saint Luke's Health System's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Chronic Heart Failure With Preserved Systolic Function is the condition Saint Luke's Health System studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Chronic Heart Failure With Preserved Systolic Function trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Saint Luke's Health System pipeline card: 26 registered trials from official public datasets.Report a data error.